Загрузка...
Current status of biosimilars in the treatment of inflammatory bowel diseases
Introduction of biological therapies have led to dramatic changes in the management of debilitating immune-mediated inflammatory bowel diseases (IBD) including ulcerative colitis and Crohn's disease. However, the long term use of these agents may be very expensive, placing a significant burden...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Association for the Study of Intestinal Diseases
2016-01-01
|
| Серии: | Intestinal Research |
| Предметы: | |
| Online-ссылка: | http://www.irjournal.org/upload/pdf/ir-14-15.pdf |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|